From Wikipedia, the free encyclopedia
A research group led by Raphael Mechoulam at Hebrew University has synthesized many cannabinoids. Some of those are:
- HU-210 — a high affinity CB1 agonist (Ki = 0.23 nM) [1]
- HU-211 — the (+)-enantiomer of HU-210 with dramatically reduced CB1 affinity [1]
- HU-239 — also known as ajulemic acid
- HU-243
- HU-308
- HU-320
- HU-331
- HU-336
- HU-345
See also
- List of AM cannabinoids
- List of CP cannabinoids
- List of JWH cannabinoids
- List of miscellaneous designer cannabinoids
References
- ^ a b Howlett, AC; Champion, TM; Wilken, GH; Mechoulam, R (February 1990). "Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor". Neuropharmacology. 29 (2): 161–5. doi: 10.1016/0028-3908(90)90056-W. PMID 2158635. S2CID 28602221.
Retrieved from "
https://en.wikipedia.org/?title=List_of_HU_cannabinoids&oldid=1098924924"
From Wikipedia, the free encyclopedia
A research group led by Raphael Mechoulam at Hebrew University has synthesized many cannabinoids. Some of those are:
- HU-210 — a high affinity CB1 agonist (Ki = 0.23 nM) [1]
- HU-211 — the (+)-enantiomer of HU-210 with dramatically reduced CB1 affinity [1]
- HU-239 — also known as ajulemic acid
- HU-243
- HU-308
- HU-320
- HU-331
- HU-336
- HU-345
See also
- List of AM cannabinoids
- List of CP cannabinoids
- List of JWH cannabinoids
- List of miscellaneous designer cannabinoids
References
- ^ a b Howlett, AC; Champion, TM; Wilken, GH; Mechoulam, R (February 1990). "Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor". Neuropharmacology. 29 (2): 161–5. doi: 10.1016/0028-3908(90)90056-W. PMID 2158635. S2CID 28602221.
|
Phytocannabinoids ( comparison) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endocannabinoids |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Synthetic cannabinoid receptor agonists / neocannabinoids |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| Allosteric CBRTooltip Cannabinoid receptor ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Endocannabinoid enhancers (inactivation inhibitors) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Anticannabinoids (antagonists/inverse agonists/antibodies) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Retrieved from "
https://en.wikipedia.org/?title=List_of_HU_cannabinoids&oldid=1098924924"